JC
SLXP

Jetstream Capital’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Jetstream Capital’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,000
Closed -$2.17M – 50
2014
Q2 		$1.85M Buy
+15,000
New +$1.66M 0.05% 30

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jetstream Capital's SLXP Position: Q3 2014 in Review

Jetstream Capital sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q3 2014, closing a stake of 15,000 shares — an estimated $2.17M sold.

Jetstream Capital first reported a position in SLXP in Q2 2014 and held it in 1 quarter. The position peaked at $1.85M in Q2 2014. 348 funds tracked by Wall St. Rank hold SLXP as of Q3 2014.

  • Jetstream Capital reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q3 2014 after selling out during the quarter.
  • Jetstream Capital sold 15,000 SALIX PHARMACEUTICALS LTD DEL shares in Q3 2014, an estimated $2.17M.
  • Jetstream Capital first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2014 and held it in 1 quarter.
  • Jetstream Capital's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.85M in Q2 2014.
  • 348 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2014.

Based on Jetstream Capital's 13F filing for Q3 2014, filed 14 Nov 2014.